AllNewsPhotosVideos

Monika Tandon, News

Monika tandon, Latest News

First nasal spray for treating adult COVID-19 patients launched in India - Hindi News | First nasal spray for treating adult COVID-19 patients launched in India | Latest national News at Lokmattimes.com

National :First nasal spray for treating adult COVID-19 patients launched in India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19. ...

Katha Pachisi - the story bank steps ahead to harness the power of storytelling for better communication - Hindi News | Katha Pachisi - the story bank steps ahead to harness the power of storytelling for better communication | Latest business News at Lokmattimes.com

Business :Katha Pachisi - the story bank steps ahead to harness the power of storytelling for better communication

Katha Pachisi is a communication platform that harnesses the power of storytelling to communicate effectively. ...

Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment - Hindi News | Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment | Latest health News at Lokmattimes.com

Health :Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment

New Delhi, Aug 6 Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to ... ...

Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment - Hindi News | Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment | Latest business News at Lokmattimes.com

Business :Glenmark introduces higher strength of FabiFlu to reduce pill burden of Covid-19 treatment

Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India. ...

Glenmark to start trial combining 2 anti-viral drugs on India Covid patients - Hindi News | Glenmark to start trial combining 2 anti-viral drugs on India Covid patients | Latest health News at Lokmattimes.com

Health :Glenmark to start trial combining 2 anti-viral drugs on India Covid patients

Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of ... ...

Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19 - Hindi News | Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19 | Latest business News at Lokmattimes.com

Business :Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19

Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy. ...

Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India - Hindi News | Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India | Latest business News at Lokmattimes.com

Business :Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so. ...